Bioinformatics Partnering Terms and Agreements Report Now Available from URCH Publishing

LONDON - March 20, 2013 - PRLog -- URCH Publishing Ltd, a leading provider of business information for the pharmaceutical industry, announces additional of a report which provides provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies.

Bioinformatics Partnering Terms and Agreements Report (http://www.urchpublishing.com/publications/sales__marketing/bioinformatics_partnering_terms_agreements.html) provides  the reader with a detailed understanding and analysis of how and why companies enter bioinformatics partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors bioinformatics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This 1000+page report provides details of the latest bioinformatics agreements announced in the healthcare sectors. Bioinformatics deals have increased in terms of popularity for partnering in the past decade, as computing power has been embraced in order to speed up the discovery, evaluation and clinical assessment processes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

Now in its 3rd edition, the report contains a comprehensive listing of all bioinformatics partnering deals announced since January 2007, including financial terms where available, including over 1500 links to online deal records of actual bioinformatics partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

In addition, a comprehensive appendix is provided organized by bioinformatics partnering company A-Z , deal type definitions and bioinformatics partnering agreements example.

Bioinformatics Partnering Terms and Agreements provides the reader with the following key benefits:

In-depth understanding of bioinformatics deal trends since 2007
Access to headline, upfront, milestone and royalty data
Analysis of the structure of bioinformatics agreements with numerous real life case studies
Comprehensive access to over 1500 actual vaccine contracts entered into by the world’s biopharma companies
Detailed access to actual bioinformatics contracts enter into by the leading fifty bigpharma companies
Insight into the terms included in a bioinformatics agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

http://www.urchpublishing.com/publications/sales__marketing/bioinformatics_partnering_terms_agreements.html